Collaboration Will Provide Protein Production and Analysis for HTI’s Cryo-EM Services
CLEVELAND, Ohio, July 29, 2024 – Health Technology Innovations (HTI), a leader in AI automation in pharma research, and KanPro Research, Inc., a protein production contract research organization (CRO) headquartered in the Kansas University Innovation Park, announced a deep collaboration today to integrate KanPro protein production and analysis into HTI Cryo-EM service delivery. This collaboration will provide new levels of efficiency for protein production, analysis and cryo-EM teams to work with a single service provider. Targeted services will deliver protein samples optimized for cryo-EM structure determination providing time and cost savings rapidly producing and screening quality proteins for structure determination.
“HTI is leveraging its deep knowledge of the cryo-EM process to deliver groundbreaking services to pharma researchers,” said Tuan Phamdo, CEO and Founder of HTI. “KanPro was exactly the right partner to combine protein production with our current suite of service offerings. This collaboration is a game changer in the full value we can deliver to our service customers.”
“KanPro has a proven history of quality protein sample production that ultimately are leveraged for cryo-EM analysis.” said Philip Gao, PhD, President of KanPro Research. “Deep integration of our protein production capability into HTI’s services gives us access to new market opportunities and provides both
companies with an opportunity to learn from each other, providing better solutions for all of our
customers.”
The news comes at the industry’s premier microscopy event, Microscopy and Microanalysis, where HTI will be featuring demonstrations of its CryoFAST software for automated cryo-EM image collection. To learn more about HTI’s Cryo-EM services, please engage info@hti.ai.
About HTI:
HTI is a leading innovator in delivering AI automation and acceleration to the pharmaceutical industry. Founded in 2019, HTI’s leadership team combines deep knowledge of the confluence of drug research, artificial intelligence, and computing innovation to deliver tools that deliver value directly to drug research teams and scale across a $1.6 trillion dollar industry. HTI is led by founder and CEO Tuan Phamdo, a seasoned tech industry leader with decades of experience at Intel, working with the
technology industry to deliver disruptive innovation to customers. HTI’s advisors are leaders in their respective fields with collective experience across healthcare, pharmaceutical, research, and technology arenas. HTI is a grant recipient of the National Science Foundation as well as Oregon Business.
About KanPro:
KanPro Research, Inc., located at the KU Innovation Park on the University of Kansas west campus, is a specialized contract research organization (CRO) that arose from the highly successful KU COBRE Protein Production Group (PPG). The company excels in producing difficult proteins, whether natural or recombinant, utilizing bacterial, yeast, insect, and cell-free expression systems. Equipped to perform large-scale bacterial culture R&D employing industrial and scalable fermenters, KanPro Research also collaborates with two international partners for the synthesis of research-grade peptides and GMP-level protein production.
Having preferential access to all core facilities at the University of Kansas, KanPro Research offers their expertise to both academic and industrial researchers. The company seeks collaborations to develop and execute contract research projects, focusing on the production of challenging proteins.